Semzuvolimab

Modify Date: 2024-01-27 14:48:47

Semzuvolimab structure	Common Name	Semzuvolimab
	CAS Number	2409099-32-5	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Semzuvolimab

Semzuvolimab is a murine IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Murine CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection[1][2].

Name	Semzuvolimab

Description	Semzuvolimab is a murine IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Murine CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Anti-infection >> HIV
References	[1]. Wang Changyi, et al. Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patients. World Intellectual Property Organization, WO2018035001 A1. 2018-02-22. [2]. Semzuvolimab. IMGT/mAb-DB.

Description

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> Anti-infection >> HIV

References

[1]. Wang Changyi, et al. Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patients. World Intellectual Property Organization, WO2018035001 A1. 2018-02-22.

[2]. Semzuvolimab. IMGT/mAb-DB.

No Any Chemical & Physical Properties